ORTHOVITA
Orthovita is a spine and orthopedic biosurgery company that manufactures and markets orthobiologic and biosurgery products. Its orthobiologics platform offers products for the fusion, regeneration, and fixation of human bones; and the biosurgery platform provides products for controlling intra-operative bleeding. Orthovita sells its products directly, as well as through non-stocking distributors and independent sales agents in the United States; and directly and through independent stocking distributors internationally. The company has strategic partnerships with Kensey Nash Corporation, Angiotech Pharmaceuticals, and Medafor. It was founded in 1992 and is based in Malvern, Pennsylvania.
ORTHOVITA
Industry:
Biopharma Health Care Manufacturing Medical
Founded:
1992-01-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Total Employee:
51+
Status:
Active
Total Funding:
32.5 M USD
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Current Advisors List
Stock Details
Investors List
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Post-IPO Equity - Orthovita
SV Health Investors
SV Health Investors investment in Venture Round - Orthovita
More informations about "Orthovita"
Orthovita Company Profile 2024: Valuation, Investors ... - PitchBook
Orthovita General Information Description. Developer of orthobiologic and biosurgery products. The company develops and markets medical implants and offers products for the fusion, …See details»
Stryker Completes Acquisition of Orthovita, Inc.
Kalamazoo, Michigan - June 28, 2011 - Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of Orthovita, Inc., a global developer and …See details»
Stryker - Stryker Announces Definitive Agreement to Acquire …
Kalamazoo, Michigan - May 16, 2011- Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire Orthovita, Inc. (Nasdaq:VITA), a global developer and …See details»
Orthovita Inc - Company Profile and News - Bloomberg Markets
Orthovita, Inc. manufactures and markets orthobiologic and biosurgery products. The Company offers products for the fusion, regeneration, and fixation of human bones, as well as controlling …See details»
Orthovita - Funding, Financials, Valuation & Investors - Crunchbase
Orthovita is a spine and orthopedic biosurgery company that manufactures and markets orthobiologic and biosurgery products. Search Crunchbase. ... How much funding has this …See details»
EW Healthcare Partners - Portfolio - Orthovita
May 17, 2011 Orthovita. Orthopedic surgical biomaterials company offering bone regeneration and soft tissue healing technologies. Based in Malvern, Pennsylvania, Orthovita, Inc. was a …See details»
Orthovita - Ownership and Business Overview - Mergr
May 16, 2011 Orthovita was founded in 1992. Medical Products M&A Summary in 2011 Out of 60 sectors in the Mergr database, medical products ranked 7 in number of deals in 2011 .See details»
Orthovita - Crunchbase
Orthovita is a spine and orthopedic biosurgery company that manufactures and markets orthobiologic and biosurgery products. Search Crunchbase. Start Free Trial . Chrome …See details»
Orthovita - Ben Franklin Technology Partners
Orthovita is an orthobiologics and biosurgery company that develops and markets innovative medical implants. Our orthobiologics platform offers products for the fusion, regeneration and …See details»
orthovita.com Company Profile | Management and Employees List
Orthovita competes in the $5 billion orthobiologics market and is a provider of synthetic bone grafts with its Vitoss product offering, and also competes in vertebral augmentation with …See details»
Orthovita, Inc. Company Profile | Philadelphia, PA | Competitors ...
Find company research, competitor information, contact details & financial data for Orthovita, Inc. of Philadelphia, PA. Get the latest business insights from Dun & Bradstreet.See details»
Orthovita, Inc. | Stryker Orhtobiologics - CAGE.report
Nov 23, 2013 ORTHOVITA, INC. DUNS 849227939 / 84-922-7939 STRYKER ORHTOBIOLOGICS. NCAGE Code: 065T5. ORTHOVITA, INC.!DBA STRYKER …See details»
Stryker Announces Definitive Agreement to Acquire Orthovita Inc.
May 16, 2011 The acquisition of Orthovita is highly complementary to Stryker’s existing orthobiologics offering, which is currently sold through multiple Stryker divisions. Under the …See details»
ORTHOVITA : Orthovita, Inc. Agrees To Be Acquired by Stryker ...
May 16, 2011 In addition, shareholder Essex Woodlands Health Ventures Fund VII, L.P., whose representative R. Scott Barry is a member of Orthovita's Board of Directors, as well as Messrs. …See details»
Stryker to buy Orthovita for $316 million | Reuters
May 16, 2011 Stryker Corp <SYK.N> plans to buy Orthovita Inc <VITA.O>, maker of biologics used in spine surgery, for about $316 million, continuing a consolidation trend in the …See details»
Orthovita: The Most Natural Thing - insights.citeline.com
The spinal orthopedics business, long focused on traditional fixation tools such as screws, dowels, cements, and more recently, interbody fusion cages, has been undergoing a slow evolution …See details»
Orthovita - Contacts, Employees, Board Members, Advisors
Organization. Orthovita . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Number of Board Member and Advisor …See details»
Orthovita Inc : Orthovita Receives FDA Approval to Market Its …
Jun 16, 2006 "A high level of coordination and performance was required throughout our organization to manage existing VITAGEL supply and obtain the pre-market approval within a …See details»
ORTHOVITA : Receives FDA Clearance for Vitoss? Bimodal Bone …
Feb 10, 2011 This press release may contain forward-looking statements regarding Orthovita's current expectations of future events that involve risks and uncertainties, including, without …See details»